Dawei Yang
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 1
-
- Flavonoids in Medical Research 3
- Co-authors
- Na Lu (7 shared papers)Binyan Lin (4 shared papers)Xiuming Song (1 shared paper)Jie Yin (1 shared paper)Xingling Yi (1 shared paper)Wei Zhang (1 shared paper)Yong-Bin Ding (2 shared papers)Tao Wu (2 shared papers)
- Journals
- Archives of Toxicology (2 papers)Journal of Cellular Physiology (2 papers)Antiviral Research (1 paper)Biochemical Pharmacology (1 paper)Life Sciences (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Dawei Yang
16 papers receiving 682 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 93
- Oncology 121
- Pulmonary and Respiratory Medicine 146
- Molecular Biology 178
- Pharmacology 40
Countries citing papers authored by Dawei Yang
This map shows the geographic impact of Dawei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Yang more than expected).
Fields of papers citing papers by Dawei Yang
This network shows the impact of papers produced by Dawei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Yang. The network helps show where Dawei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 315 | |
| 2 | 2022 | 98 | |
| 3 | 2008 | 70 | |
| 4 | 2020 | 56 | |
| 5 | 2021 | 44 | |
| 6 | 1996 | 24 | |
| 7 | 2022 | 22 | |
| 8 | 2017 | 21 | |
| 9 | 2018 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2024 | 7 | |
| 12 | 2021 | 5 | |
| 13 | P15, MDM2, NF-κB, and Bcl-2 expression in primary bone tumor and correlation with tumor formation and metastasis. | 2015 | 4 |
| 14 | 2025 | 3 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 0 |
About Dawei Yang
Dawei Yang is a scholar working on Oncology, Pharmacology, Infectious Diseases, Virology and Physiology, having authored 17 papers that have together received 692 indexed citations. Recurring topics across this work include Flavonoids in Medical Research (3 papers), Telomeres, Telomerase, and Senescence (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Bone Tumor Diagnosis and Treatments (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Diabetes Management and Research (1 paper). The work is most often cited by research in Cancer Research (93 citations), Oncology (121 citations), Pulmonary and Respiratory Medicine (146 citations), Molecular Biology (178 citations) and Pharmacology (40 citations). Dawei Yang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Na Lu, Binyan Lin, Xiuming Song, Jie Yin, Xingling Yi, Wei Zhang, Yong-Bin Ding, Tao Wu, Qinglong Guo and Xiaoyu Tian. Their work appears in journals such as Archives of Toxicology, Journal of Cellular Physiology, Antiviral Research, Biochemical Pharmacology and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.